HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Psychopharmacologic treatment of dissociative fugue and PTSD in an Ethiopian refugee.

Abstract
Despite widespread awareness of their frequent co-occurrence, little is known about treatment of individuals with comorbid posttraumatic stress disorder (PTSD) and dissociative disorders. Patients with dissociative disorders do not respond well to standard exposure therapy, and few psychopharmacologic trials exist. Fluoxetine proved ineffective for depersonalization disorder, but paroxetine showed efficacy in decreasing dissociative symptoms in PTSD patients.
AuthorsDorothy Liu-Barbaro, Murray Stein
JournalThe Journal of clinical psychiatry (J Clin Psychiatry) Vol. 76 Issue 7 Pg. 958 (Jul 2015) ISSN: 1555-2101 [Electronic] United States
PMID26115334 (Publication Type: Case Reports, Journal Article)
Copyright© Copyright 2015 Physicians Postgraduate Press, Inc.
Chemical References
  • Adrenergic alpha-1 Receptor Antagonists
  • Serotonin Uptake Inhibitors
  • Sertraline
  • Prazosin
Topics
  • Adrenergic alpha-1 Receptor Antagonists (administration & dosage, pharmacology)
  • Comorbidity
  • Dissociative Disorders (diagnosis, drug therapy)
  • Ethiopia
  • Humans
  • Male
  • Middle Aged
  • Prazosin (administration & dosage, pharmacology)
  • Refugees (psychology)
  • Selective Serotonin Reuptake Inhibitors (administration & dosage, pharmacology)
  • Sertraline (administration & dosage, pharmacology)
  • Stress Disorders, Post-Traumatic (diagnosis, drug therapy)
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: